The Suraksha Diagnostic IPO is set to hit the market, offering investors a chance to tap into the fast-growing healthcare sector. With a price band of ₹420-441 per share, this IPO promises to deliver value through its robust operations, financial performance, and strategic market positioning.
Key Details of the IPO
Suraksha Diagnostic IPO Overview
| Parameter | Details |
|---|---|
| Price Band | ₹420-441 per share |
| Subscription Dates | Nov 29 – Dec 3, 2024 |
| Lot Size | 34 shares and multiples thereof |
| Issue Size | Entirely Offer for Sale (OFS) |
| Allocation | 50% QIB, 15% NII, 35% Retail |
| Listing Date | Dec 6, 2024 |
Suraksha Diagnostic: A Healthcare Pioneer
Suraksha Diagnostic stands out as a leading provider of integrated diagnostic services. Key offerings include:
- Comprehensive Testing: Over 2,300 pathology and radiology tests.
- State-of-the-Art Facilities: Operates 43 centers and 120 polyclinics.
- Experienced Workforce: 750+ doctors providing quality care.
Financial Performance
The company has demonstrated consistent growth:
- Revenue Growth: 14.75% increase in FY24 compared to FY23.
- Profit After Tax (PAT): Surged by 281.32% between FY23 and FY24.
Comparison with Industry Peers
Peer Comparison
| Company | P/E Ratio | Revenue Growth | PAT Growth |
|---|---|---|---|
| Suraksha Diagnostic | 77.08 | 14.75% | 281.32% |
| Dr Lal PathLabs | 77.08 | 12% | 140% |
| Metropolis Healthcare | 89.61 | 10% | 120% |
| Thyrocare | 65.52 | 8% | 110% |
Expert Recommendations
- Short-Term Perspective:
- Suraksha Diagnostic IPO is a viable option for listing gains.
- Long-Term View:
- Its diversified portfolio and consistent growth make it an attractive choice for long-term investors.
MUST READ: Mutual Fund-to-ETF Conversions: A Winning Strategy for US…
Is This IPO for You?
Suraksha Diagnostic IPO offers a unique opportunity to invest in a rapidly growing sector. However, its reliance on an Offer for Sale (OFS) model means that all proceeds go to existing shareholders, not the company. Consider this if you’re looking for growth-oriented investments.
Disclaimer: Investments in IPOs are subject to market risks. Please consult a financial advisor to determine the suitability of this investment for your portfolio.
Click here to know more: here
